1. Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN;
2. Department of Pediatrics and Developmental Biology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan;
3. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN;
4. Department of Pediatrics, Graduate School of Medicine, Mie University, Mie, Japan;
5. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;
6. Department of Clinical Pharmacology, University of Tuebingen, Stuttgart, Germany;
7. Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany;
8. Department of Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany;
9. St. Luke’s International Hospital, Tokyo, Japan;
10. Khoo Teck Puat–National University Children’s Medical Institute, National University Hospital, National University Health System, Singapore;
11. VIVA-NUS Center for Translational Research in Acute Leukaemia, Department of Paediatrics, Yong Loo Lin School of Medicine, Singapore;
12. Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX;
13. Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan;
14. Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan;
15. Cancer Science Institute of Singapore, National University of Singapore, Singapore; and
16. Department of Oncology and
17. Hematological Malignancies Program, Comprehensive Cancer Center, St. Jude Children’s Research Hospital, Memphis, TN